Ablynx NvCompany Details

Get alertedif Ablynx Nv gets funded!
Company description

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonology.


Funding history

DateDeal sizeInvestors 
October 28th, 2017$200,000,000-View Deal
Create alert
Want to know when Ablynx Nv gets funded?
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!